Exparel 266 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFBS6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,110
Award facts
- Contract value 100% obligated
- $28,109.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,109.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 266 mg/20 mL vials of EXPAREL, a specialty surgical anesthetic product. The delivery order, issued on December 23, 2025, with an ultimate completion date of January 15, 2026, carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully against other qualified vendors in an unrestricted procurement. DMS Pharmaceutical Group holds no identified subcontractors on this award.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs across Department of Defense healthcare facilities worldwide. The parent IDC, designated SPE2DR and awarded on November 13, 2025, establishes a 30-month base period with three 30-month option periods extending through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional prime vendor contractor within the broader military medical supply chain. The company's extensive product portfolio and demonstrated performance across multiple therapeutic categories underscore its role as a key supplier for federal pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DR26FFBS6?
SPE2DR26FFBS6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FFBS6 worth?
The government has obligated $28,110 on SPE2DR26FFBS6.
Is contract SPE2DR26FFBS6 an order under another contract?
Yes. SPE2DR26FFBS6 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBS6 competed?
The extent of competition for SPE2DR26FFBS6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award